The Diversity Jurisdiction Inflation Adjustment Act updates the minimum monetary threshold required for federal courts to hear cases based on diversity of citizenship. It raises the current limit of $75,000 to $150,000 and establishes a mechanism to automatically adjust this amount every ten years starting in 2030 based on changes in the Consumer Price Index. The Director of the Administrative Office of the United States Courts will calculate these adjustments and publish them annually, ensuring the threshold keeps pace with inflation. Additionally, the bill clarifies that if a plaintiff recovers less than the required amount, the court may deny or impose costs on them. This legislation directly affects individuals and businesses seeking to file civil lawsuits in federal court by changing the financial requirements for jurisdiction.
This bill extends the funding authorization for the Accelerating Access to Critical Therapies for ALS Act from 2026 to 2031, ensuring continued financial support for research into treatments for amyotrophic lateral sclerosis. It requires the Food and Drug Administration to review clinical trial data more rigorously by assessing patient enrollment numbers and requesting interim results from drug manufacturers before renewing research grants. Additionally, the legislation clarifies that clinical trials in phase 3 include combined phase 2/3 studies and planned trials that have not yet started enrolling participants. The bill also mandates the FDA to publish a report within a year of enactment detailing its progress on rare neurodegenerative disease action plans and how it coordinates with broader disease communities. Finally, it adjusts the timeline for a Government Accountability Office report to cover a five-year period instead of four.
This bill raises the debt thresholds for qualifying for certain bankruptcy protections under U.S. law. It increases the small business bankruptcy limit (Chapter 11) from $750,000 to $7.5 million in total debts, allowing more small business owners to file. For consumer bankruptcy (Chapter 13), it raises the individual debt limit from $1 million to $2.75 million (or $2.75 million for a couple), excluding stockbrokers and commodity brokers. The changes apply to cases filed after the bill's enactment, directly affecting small business owners and consumers with higher debt levels who previously couldn't qualify.
This bill extends two existing public health programs focused on tick-borne diseases through 2030. It updates the funding timeline for national vector-borne disease centers and health department support from 2021-2025 to 2026-2030. The bill does not change program content or eligibility but ensures continued funding for efforts addressing tick-related illnesses. It directly affects public health agencies administering these programs, not specific individuals.
This resolution designates the week of August 22 through August 30, 2026, as "National Park Week." It directly affects the public by encouraging responsible visits and support for the National Park System, which includes parks, battlefields, and historical sites located across the United States and its territories. The measure serves as a formal declaration to highlight the parks' role in recreation, education, and economic activity without altering any laws or funding.
This resolution designates August 16, 2026, as National Airborne Day to honor the history and contributions of U.S. airborne military forces. The bill calls on the American people to observe the day with programs and ceremonies celebrating the bravery and achievements of paratroopers and air assault units. It highlights the legacy of these forces, which began with the first official Army parachute jump on that date in 1940 and have since served in numerous conflicts worldwide. The measure serves as a commemorative recognition rather than a change to federal law or military operations.
This Senate resolution commemorates June 19, 2026, as Juneteenth National Independence Day to honor the 1865 announcement of freedom to enslaved people in Texas and the Southwestern States. The bill serves as a formal recognition of this historical event and does not create new laws or change federal holidays. It aims to support nationwide celebrations and encourage learning about the history of slavery and emancipation in the United States.
This bill reauthorizes and expands the Accelerating Access to Critical Therapies for ALS Act through 2031, extending funding for research into treatments for amyotrophic lateral sclerosis. It requires drug manufacturers to share interim clinical trial data with the FDA to better assess the progress of investigational drugs and clarifies that phase 3 clinical trial definitions include combined phase 2/3 trials and planned trials not yet enrolling participants. The legislation also mandates the FDA to publish an updated five-year action plan for ALS and other rare neurodegenerative diseases, including resource needs and coordination strategies with broader disease communities. Additionally, the bill requires the Government Accountability Office to submit a report on the program's implementation four years after enactment.
This bill reauthorizes and updates the American Battlefield Protection Program through 2036, extending funding for battlefield preservation grants. It increases the maximum grant percentage for battlefield interpretation projects from 50% to 75% and sets $2 million annually for battlefield restoration grants through 2036. The bill also requires the National Park Service to study French and Indian War (1754-1763) and Mexican-American War (1846-1848) sites across the U.S., assessing their significance, threats, and preservation options. These studies must involve state governors, tribal governments, local officials, and historic preservation groups, with a final report due to Congress within two years of funding. The program directly affects federal, state, tribal, and local entities managing historic battlefields.
This bill reauthorizes federal programs focused on preventing and responding to tick-borne diseases through 2026-2030, extending existing efforts beyond their previous expiration. It updates the National Strategy for Vector-Borne Diseases to emphasize identifying, reporting, preventing, and responding to these illnesses. The bill modifies two sections of the Public Health Service Act to continue funding for health departments working on vector-borne disease control. It directly affects public health programs and state/local health departments managing tick-borne disease prevention and response.
The AADAPT Act reauthorizes and expands Project ECHO grants to improve Alzheimer’s and dementia care through technology-enabled training. It specifically funds grants for healthcare providers in rural, frontier, or medically underserved areas to enhance early diagnosis, quality care, and provider retention for dementia patients. The bill authorizes $1 million annually (2027-2032) for these dementia-focused training programs, requiring funds to supplement - not replace - existing resources. This directly supports primary care providers licensed to serve underserved communities, using collaborative online learning to address care gaps.
HR 2913, the Ukraine Support Act, provides comprehensive U.S. support for Ukraine in response to Russia's invasion. The bill authorizes security assistance including lend-lease authority for military equipment, establishes a Ukraine Reconstruction Trust Fund for economic recovery, and imposes new sanctions targeting Russian financial institutions, oil companies, and government officials. It also includes provisions to counter Russian disinformation, support Radio Free Europe, and address the kidnapping of Ukrainian children. The legislation directly affects U.S. foreign policy, Ukraine's defense capabilities, and Russia's access to international financial systems. The act aims to strengthen Ukraine's sovereignty while holding Russia accountable for its actions.
